SCHEMBL13871869

SCHEMBL13871869

C=C1c2cc(Cl)ccc2CN1c1ccc2c(c1)cc(C)n2C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.34
▸ MEN1 O00255 6/20 0.33
▸ KMT2A Q03164 6/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ PABPC1 P11940 2/20 0.32
▸ ALOX15 P16050 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ S100A4 P26447 1/20 0.32
▸ EIF4H Q15056 1/20 0.32
▸ CBLB Q13191 1/20 0.32
▸ HPGD P15428 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13872273 0.88 METAP1 (0.35) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13113642 0.86 HTR2C (0.47) HTR2CMEN1KMT2AKDM4EALDH1A1
SCHEMBL14818556 0.84 HTR1A (0.32) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13871905 0.84 MEN1 (0.39) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13871937 0.84 MEN1 (0.36) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13872217 0.82 PRKCI (0.39) HTR2CTHRBHTR2ACBLBACHE
SCHEMBL13871950 0.82 MEN1 (0.38) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13872259 0.81 MEN1 (0.39) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL13871966 0.80 MEN1 (0.40) HTR2CMEN1KMT2AKDM4EALDH1A1
SCHEMBL13871983 0.79 MEN1 (0.40) MEN1KMT2AKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009042907-A1 ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-04-02 — — WO disclosed
Send feedback